Showing results (1531-1540 of 1,714) with videos related to

Sort By:
Pageof 172
Cell Cycle (Georgetown, Tex.)|April 15, 2016
Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53Wen-Ting Liu, Ying-Ying Jing, Guo-feng Yu, et al.
JACC. Cardiovascular Interventions|May 1, 2017
Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry StudySui-Ji Li, Zhen Ge, Jing Kan, et al.
Cardiovascular Therapeutics|September 8, 2012
Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trialShao-Liang Chen, Fei Ye, Jun-Jie Zhang, et al.
Patient Preference and Adherence|July 23, 2013
Two-year clinical outcomes after coronary drug-eluting stent placement in Chinese men and women: a multicenter, prospective registry studyRajiv Shrestha, Sandeep Gami, Jing Xu, et al.
BMC Cancer|August 1, 2021
A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancerWanjun Yu, Fei Ye, Xiao Yuan, et al.
Science Advances|October 10, 2025
Structural insights into the progressive recovery of α7 nicotinic acetylcholine receptor from nicotine-induced desensitizationSanling Liu, Haopeng Chen, Xiaohong Zhu, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 26, 2026
Dynamic FIB-4 trajectory and a multi-state Markov model analysis reveal fibrosis progression and cardiovascular-cerebrovascular risk in MAFLD patientsXin-Yu Fu, Si-Yan Yan, Ya-Qi Song, et al.
Biomedical and Environmental Sciences : BES|June 21, 2019
Next-generation Sequencing Study of Pathogens in Serum from Patients with Febrile Jaundice in Sierra LeoneYi Zhang, Fei Ye, Lian Xu Xia, et al.
The American Journal of Pathology|January 13, 2015
RSK1 activation promotes invasion in nodular melanomaAmel Salhi, Joshua A Farhadian, Keith M Giles, et al.
Oncoimmunology|March 17, 2023
Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentationsBenjamin C Park, Sathya Narayanan, Alexander Gavraldis, et al.
Pageof 172